Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2

Atherosclerosis. 2011 Feb;214(2):345-9. doi: 10.1016/j.atherosclerosis.2010.11.018. Epub 2010 Nov 27.

Abstract

Objective: Macrophages are key players in atherogenesis because of their properties to form foam cells that produce a large variety of pro-inflammatory mediators. We addressed the potency of phenotypic different macrophages to accumulate oxidized LDL.

Methods and results: Surprisingly, anti-inflammatory M2 macrophages but not pro-inflammatory M1 macrophages rapidly accumulated oxidized LDL. Simultaneously, expression of Krüppel-like factor 2, a nuclear transcription factor known to suppress inflammation in endothelial cells and monocytes, decreased and the functional phenotype of M2 macrophages shifted towards a pro-inflammatory profile, characterized by higher production of IL-6, IL-8 and MCP-1 and lower expression of IL-10 upon stimulation with LPS. In contrast, Krüppel-like factor 2 expression and the phenotype of M1 macrophages remained largely unchanged upon oxidized LDL exposure. Downregulation of Krüppel-like factor 2 expression of M2 macrophages using siRNA technology led to a significant increase of LPS-induced MCP-1 secretion.

Conclusions: We show that (1) anti-inflammatory M2 macrophages are more susceptible to foam cell formation than pro-inflammatory M1 macrophages, (2) exposure to oxidized LDL renders M2 macrophages pro-inflammatory, and (3) Krüppel-like factor 2 is involved in the enhanced secretion of MCP-1 by M2 macrophages loaded with oxidized LDL. The phenotype switch of M2 macrophages from an anti- to a pro-inflammatory profile may play an important role in pathogenesis of atherosclerosis, and could represent a novel therapeutic target.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / genetics
  • Atherosclerosis / immunology
  • Atherosclerosis / metabolism*
  • Cells, Cultured
  • Chemokine CCL2 / metabolism
  • Cytokines / metabolism*
  • Foam Cells / drug effects
  • Foam Cells / immunology
  • Foam Cells / metabolism*
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism
  • Humans
  • Inflammation Mediators / metabolism*
  • Interleukin-10 / metabolism
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Kruppel-Like Transcription Factors / genetics
  • Kruppel-Like Transcription Factors / metabolism*
  • Lipopolysaccharides / pharmacology
  • Lipoproteins, LDL / metabolism*
  • Macrophage Activation* / drug effects
  • Macrophage Colony-Stimulating Factor / metabolism
  • Macrophages / drug effects
  • Macrophages / immunology
  • Macrophages / metabolism*
  • Phenotype
  • RNA Interference
  • Time Factors
  • Transfection

Substances

  • CCL2 protein, human
  • CXCL8 protein, human
  • Chemokine CCL2
  • Cytokines
  • IL10 protein, human
  • IL6 protein, human
  • Inflammation Mediators
  • Interleukin-6
  • Interleukin-8
  • KLF2 protein, human
  • Kruppel-Like Transcription Factors
  • Lipopolysaccharides
  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Interleukin-10
  • Macrophage Colony-Stimulating Factor
  • Granulocyte-Macrophage Colony-Stimulating Factor